Abstract

Objective. To examine the effectiveness of robot-assisted therapy (RAT) combined with conventional therapy (CT) compared to CT alone in accelerating upper extremity (UE) recovery poststroke. Data Sources. We searched five databases: Ovid, MEDLINE, CINAHL, PubMed, and Scopus Study Selection. Studies were selected for this review using the following inclusion criteria: randomized controlled trials of adults, RAT combined with CT compared to CT, and Fugl-Meyer Assessment (FMA) as an outcome measure. Studies focused on children with neurological impairments, and studies that used RAT to facilitate lower extremity recovery and/or improve gait were excluded. Data Extraction. The initial search yielded 3,019 citations of articles published between January 2011 and May 2021. Fourteen articles met the inclusion criteria. Randomization, allocation sequence concealment, blinding, and other biases were assessed. Data Synthesis. Current evidence suggests that the use of RAT along with CT may accelerate upper extremity recovery, measured by FMA, in the beginning of rehabilitation. However, the progress fades over time. More empirical research is needed to validate this observation. Also, the findings related to cost-benefit analyses of RAT are inconclusive. Conclusions. It is unclear whether RAT accelerates UE recovery poststroke when used in conjunction with conventional therapy. Given the capital and maintenance costs involved in developing and delivering RAT, more controlled studies examining the effectiveness and cost-benefit analysis of RAT are needed before it can be used widely. This trial is registered with CRD42021270824.

1. Introduction

Technological gains in rehabilitation have not only impacted the way that diagnostic testing is done, made way for less invasive surgical procedures, and allowed for the online delivery of telehealth services but have also impacted the way that direct rehabilitation can be delivered [1, 2].

The development of new technology, including robots, has been a driving force for improving the treatment for various impairments. According to Chang and Kim, a robot is “a re-programmable, multi-functional manipulator designed to move material, parts, or specialized devices through variable programmed motions to accomplish a task” [3]. The first robotic device designed for rehabilitation was created in 1992 and paved the way for robot-assisted therapy (RAT) [4]. Since then, RAT has been used to treat a wide range of skill deficits or functional impairments such as impaired social and intellectual skills, sensorimotor deficits, gait dysfunctions, decreased hand function, and decreased activity participation in clients with cerebral palsy, autism, spinal cord injury, ankle injuries, intellectual disabilities, and stroke [514]. RAT allows for repetitive practice in conjunction with conventional therapies.

Every year, more than 795,000 people have a cerebrovascular accident (stroke) in the USA [15]. Stroke is the leading cause of long-term disability with only 12% of stroke survivors obtaining complete upper limb functional recovery.

The findings related to the use of RAT to facilitate upper extremity (UE) recovery in stroke rehabilitation are equivocal despite expected potential of RAT to maximize repetitive, task-specific training. Some studies have found significantly greater functional effects of RAT when compared to conventional therapy alone while many others have not. For instance, a systematic review and meta-analysis of 11 randomized controlled trials revealed that the effects of RAT and conventional therapy were similar, and that RAT combined with CT was not superior to CT alone [16]. Another study conducted at the University of Italy also reported similar findings [17]. However, Daly et al. reported that patients with stroke who underwent robotics and motor learning interventions made significant gains in the outcome measures related to arm function [18].

As research continues to evolve, it is essential to periodically review the effectiveness of novel interventions like RAT to determine their utility in practice. Further, despite mixed findings in terms of treatment effectiveness, RAT may be superior in other measures of recovery such as cost-benefit ratio and speed of recovery. This systematic review is an attempt to critically appraise the recent literature related to RAT in stroke upper extremity rehabilitation, with a specific focus on speed of recovery as it benefits all stakeholders including patients, service providers, and insurers. For the patients, faster recovery of function means a quicker return to optimal occupational performance. For the hospitals, a faster rate of recovery means more open beds and better patient outcomes [19]. For the insurers, a rapid recovery means less money spent on coverage of services. Speed in recovery is especially important when related to stroke rehabilitation due to the nature of neuroplasticity. The greatest improvement in function following a stroke tends to occur in the first six months which is an important window to target for greatest potential of recovered function [20]. Given the importance of this treatment window for stroke rehabilitation, it is critical to utilize interventions that are effective and help maximize functional recovery as quickly as possible within this time frame.

The authors believe that this research may yield insights related to the use of RAT in UE rehabilitation poststroke and the focus on speed of recovery may help rehabilitation professionals determine the logistics involved in stroke rehabilitation. No research was found to investigate speed of recovery using RAT, making the current study novel. Thus, this systematic review is aimed at investigating the following question: Is RAT effective in accelerating the UE functional recovery of patients with stroke when combined with conventional therapies, as opposed to conventional therapy alone?

2. Methods

The formation of the methods section was guided by the preferred reporting items for systematic review and meta-analyses [21].

2.1. Literature Search

We conducted a systematic search of articles published between 2011 and May 2021 on Ovid, MEDLINE, CINAHL, PubMed, and Scopus databases on 05/27/2021. All searches ran except those on Scopus limited the search results to articles published between 2011 and 2021. Table 1 presents an overview of the literature search. All the 113 articles selected after title screening were uploaded to Rayyan, a web app for systematic review [22]. Eight articles were found to be duplicates and were removed. The remaining 105 articles were reviewed against the eligibility criteria.

Each of the first five authors reviewed a different database independently and imported chosen articles to Rayyan. Once all articles were in Rayyan, inclusion and exclusion decisions were made. The five authors’ decisions were blinded to each other until all decisions were made. All five authors then reviewed each included article, and the final inclusion decisions were made by consensus.

2.2. Eligibility Criteria

Articles were included only if the participants were adults () with stroke resulting in functional deficits in their upper extremities. Articles were excluded if they enrolled children as participants or if the primary focus was on lower extremity function or gait. We considered articles that compared some form of RAT with any type of “conventional” therapies, such as motor relearning, functional electrical stimulation (FES), therapeutic exercise, proprioceptive neuromuscular facilitation, and constraint-induced movement therapy. Articles that were excluded did not compare RAT to conventional therapy. To be included, a trial had to use the Fugl-Meyer Assessment (FMA) as an outcome measure. We chose the FMA because it is widely known and was used by many of the studies reviewed. Many studies included a variety of outcome measures in addition to the FMA, but those that did not include the FMA were excluded to allow for standardized comparisons of recovery across included evidence. We excluded the articles published before 2011 to ensure recent evidence. Further, we selected only randomized controlled trials to include highest quality evidence. All articles with an evidence level lower than 2B, per the Center for Evidence-Based Medicine’s (CEBM) Levels of Evidence table, were excluded [23]. Of the 105 articles reviewed, 87 were excluded during the screening process. The full texts of the remaining 18 articles were reviewed, and one more article was excluded because it had an evidence level lower than 2B. Three articles were later excluded because they did not include a control group (see Figure 1).

2.3. Data Extraction

The level of evidence of each article was determined using the American Occupational Therapy Association Guidelines for Systematic Review, which incorporates the CEBM evidence table [24]. These guidelines determine the level of evidence based on study design and quality. Five authors worked independently to extract the data from the articles. For each article, the level of evidence and risk of bias were determined. The following information was extracted from each article: number of participants, inclusion criteria, treatment setting, interventions that were used in the control and experimental group, outcome measures used, and results.

2.4. Risk of Bias

Risk of bias was assessed using the “Revised Tool for Assessing Risk of Bias in Randomized Trials” [25]. This tool evaluates each article based on the presence of random sequence generation, allocation concealment, baseline differences between groups, blinding of participants and study personnel, blinding of self-reported and objective outcome measures, incomplete outcome data, and selective reporting. Each study was identified as having low risk or high risk for each of these categories. The levels of risk were then summed to assess the overall risk of bias for each study. Not applicable (N/A) was selected for blinding of self-reported measures if the study did not utilize self-reported assessments. Each article was assessed for risk of bias by at least two authors. Disagreements were resolved through discussion and consensus.

2.5. Speed of Recovery

The primary outcome measure examined in this review was the speed of the UE functional recovery postrobotic therapy with concurrent CT. Speed of recovery was assessed by looking at the duration of the intervention and how much progress was made in that time, based on the FMA score. Using the formula of , the change in FMA score was divided by total hours spent in the intervention to calculate progress made per hour.

3. Results

This systematic review included 14 randomized controlled trials. Most of the studies were from Taiwan and the US, and studies from China, Australia, Korea, Germany, Italy, Switzerland, and Japan were also included. Each selected study utilized a control and an intervention group. The control groups utilized a wide range of conventional stroke rehabilitative therapies, including, but not limited to, task training, passive range of motion, functional electrical stimulation, and modified constraint-induced movement therapy. The intervention group consisted of RAT which performed passive range of motion and helped support UE recovery along with some form of conventional therapy.

The number of total participants included in the 14 studies was 1,141 with a mean number of 41 participants per study. The number of participants in the studies ranged from 17 to 770. Participants were within the age range of 20 to 85 with a median age of 57 years.

Table 2 presents the summary of the evidence extracted. Twelve articles were rated as evidence level 1B, and the remaining two were rated as evidence level 2B. Four of the 14 studies had a moderate risk of bias while the remaining 10 had a low risk of bias. Due to the nature of the robotic therapy intervention, it was impossible to blind the participants to group assignment. Although some factors such as the inability to blind participants increased the risk of bias, most of the studies had moderate to low risk of bias because they utilized random assignment, did not have baseline differences between the intervention and control groups, and used blinding procedures during outcome assessments (see Table 3).

3.1. Speed of Recovery

Values for speed of recovery were calculated for both the robotic and control groups for comparison (see Table 4). The average speed of recovery of the robotic groups was calculated to be a 0.31 increase in FMA score per hour. Likewise, the average speed of recovery of the control groups was calculated to be a 0.24 increase in FMA score per hour. Because one study [35] only utilized the hand portion of the FMA, these values were calculated separately. The speed of recovery for this study was calculated to be 0.15 FMA points per hour for the robotics group and 0.04 FMA points per hour for the control group.

3.2. Intensity

The change in FMA score was then divided by the time spent in the robotic intervention in each of the studies. The total intensity of each intervention was calculated in hours based on the length of each session, number of sessions per week, and number of weeks spent in intervention. The included studies were divided into three categories based on the number of hours that participants spent in the intervention: 10-25 hours, 26-50 hours, and more than 50 hours. Participants in seven studies spent 10-25 hours in intervention with an average of 15 hours [2632]. Participants in three studies spent 26-50 hours with an average of 39 hours [33, 37, 39]. Participants in three other studies spent more than 50 hours with an average of 156 hours [34, 36, 38]. The change in FMA points per hour in the robotics group was compared to that of the control group for the three categories (see Figure 2).

The average speed of recovery demonstrated by the participants in the 10-25 hours group was calculated as 0.44 FMA points per hour, 26-50 hours group as of 0.23 FMA points per hour, and more than 50 hours group as 0.09 FMA points per hour.

Because intervention intensity differed drastically between studies, a daily intensity value was also calculated to show changes in FMA scores per hour per day. These values were calculated by dividing total hours spent in intervention by days spent in intervention (see Table 5).

Studies were then grouped by daily intensity scores, and average change in FMA score was compared between robotics and control for each grouping as a measure of progress per hour per day: a daily intensity of low (0-0.35 hours/day), medium (0.36-0.55 hours/day), and high (0.56+ hours/day). Two studies used a low intervention intensity [31, 32]. Six studies used medium intensity [2628, 30, 36, 39]. The remaining four studies used high intensity [29, 33, 37, 38]. The average changes in FMA robotics for low, medium, and high daily intensity studies were found to be 2.42 points/hour/day, 7.57 points/hour/day, and 9.65 points/hour/day, respectively. For the control groups, the average changes in FMA score for low, medium, and high daily intensity studies were found to be 1.19 points/hour/day, 5.24 points/hour/day, and 9.16 points/hour/day, respectively (see Figure 3).

3.3. Fugl-Meyer Scores

The difference between the baseline and end FMATotal scores for the control group and the experimental group was calculated to determine the improvement in upper extremity function. Four of the included studies [26, 29, 34, 37] had a greater amount of improvement in the control group with none of them being a significant difference from the experimental, while nine studies [27, 28, 3033, 36, 38, 39] had a greater improvement in the experimental group with three of them being significant. The study that only calculated the hand FMA scores showed greater improvement in the experimental group [35].

4. Discussion

This systematic review presents an overview of the current evidence on RAT in stroke rehabilitation with a special focus on the speed of recovery. It appears that the rate of improvement in UE functional recovery with RAT decreases after 25 hours spent in intervention. This may indicate that RAT may be effective only in the initial stages of the rehabilitation phase poststroke and that progress declines over time. Fading novelty is a phenomenon that demonstrates the waning of progress as an intervention becomes familiar [40, 41]. RAT may be an intervention that is subject to this phenomenon.

Further knowledge about this decline in the postintervention speed of progress would be beneficial to help determine the effect of RAT on the speed of stroke UE recovery over time. However, all included studies assessed only FMA scores at the start and the conclusion of the intervention period. The lack of intermediate FMA scores limited the author’s ability to assess changes in speed over time. Nevertheless, significant functional progress was made within the first 25 hours in intervention which may support the use of RAT as a beneficial short-term intervention. Additionally, daily intensity scores showed greater improvement in UE functional recovery with both RAT and conventional therapy; however, RAT was shown to be slightly more effective. With both RAT and conventional therapy, greater time spent in therapy per hour per day results in greater functional improvement. This information proves that higher intensity of therapy following stroke is most beneficial for functional recovery, and RAT may help boost improvements made in the same amount of time.

4.1. Strength of Current Evidence

The findings show that RAT combined with conventional therapy did not significantly increase the speed of recovery when compared to conventional therapy alone over time. The evidence supporting this finding was rated as strong as this review appraised only high-quality evidence [42]. In addition, all reviewed articles had a low-to-moderate risk of bias.

4.2. Study Limitations and Future Directions

One limitation to this review was heterogeneity of variables. In addition, included articles examined stroke survivors of differing ages which could have impacted the recovery rate. Further, each study was performed with patients who were in different stages of stroke recovery ranging from six months to several years poststroke. This nonstandardized starting point poststroke also decreases clarity about whether functional progress was due to fading novelty or simply a normal plateau in progress. In addition, each of the studies reviewed used a different type of robot, which may also affect the rate of recovery.

An additional limitation is the differences in how RAT was used in each study. Intervention intensity among the studies included ranged from three days a week to seven days a week. Some studies had participants use RAT for 30 minutes a day while other studies used RAT for up to an hour. Finally, study duration ranged from 4 weeks to 12 weeks. The present study attempted to equalize some of these intensity differences by comparing intensity and speed using a variety of variables; however, the vast difference between included study designs is a limitation.

Future research could address these limitations by comparing studies with participants who are within the same age groups and the same length of time poststroke. Stratifying the articles into groups based on age and time since stroke could clarify the impact of these variables and help identify at which point in the recovery process the use of robotics would be the most beneficial. Future studies should also review articles that use more similar types of robots to increase the comparability of results and reduce extraneous factors that could impact the results. Reducing heterogeneity of the studies reviewed could better clarify the impact of robots as distinct from other factors such as age, time since stroke, and type of robot utilized.

In this review, a variety of conventional therapies were used such as repetitive task practice and constraint-induced movement therapy. Conventional therapies were not compared in the present review due to the vagueness of “usual care” used in some studies and the wide range of conventional therapies used. Future research could focus on comparing which of these conventional therapies is the most effective, then comparing that single CT to RAT. This method could help truly determine how RAT compares to CT.

4.3. Implications for Practice

The findings have the following implications for practice: (i)Overall intensity of the interventions and functional progress had an inverse relationship; however, higher daily intensity demonstrated a positive correlation with functional progress. Hence, rehabilitation professionals may consider using higher-intensity RAT for a shorter duration in the beginning phases of rehabilitation(ii)Practitioners must exert caution and use their best professional judgment when choosing RAT as part of their intervention as several factors such as type of the device, stage of recovery, and cost and time associated with the intervention may influence the treatment outcome(iii)Practitioners must continue to appraise the recent evidence when making treatment decisions, especially when using novel interventions like RAT

5. Conclusion

The use of RAT in stroke rehabilitation appears to accelerate arm recovery in the first two weeks postintervention but needs more validation through empirical research. Current evidence regarding the use of RAT and its effect on the UE stroke recovery suffers from the variability in studies, technology used, implementation of RAT in different phases of recovery, etc. As speed of recovery has cost implications, practitioners must take that into consideration when developing stroke rehabilitation programs. More research examining the efficacy of RAT and speed of UE recovery poststroke is warranted.

Abbreviations

RAT:Robot-assisted therapy
CT:Conventional therapy
FMA:Fugl-Meyer assessment
UE:Upper extremity.

Data Availability

This is a systematic review. Data are the articles reviewed.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

This study was supported by the University of Texas Medical Branch.